We use cookies to offer you the best experience on our site. You can find out more about the cookies we use or disable them in the Cookie settings
Zentech
Specialty
ZenTech is a biotechnology company specializing in the development and commercialization of In Vitro solutions and reagents. The tests are noninvasive and allow for the screening of rare, genetic, chronic or infectious metabolic diseases in human body fluid samples.
ZenTech specializes in supporting patients at early stages of life, focusing resources on developing a broad range of products for neonatal screening. The systematic screening performed in all asymptomatic newborns can detect the presence of serious and potentially treatable metabolic errors. This is the first essential step before a suitable treatment can be implemented to ensure optimal development and quality of life for newborns.
In order to make screening accessible to everyone, ZenTech brings its expertise to the service of developing a product line designed to match the reality of the field and any type of laboratory. From sample collection to the pre-analytical and analytical phases to results: a custom solution is available at each stage of screening.
In order to meet the growing needs of newborn screening laboratories, ZenTech has strengthened its technological expertise and offers in addition to its reputational immunoenzymatic methods and rapid tests, mass spectrometry and qPCR solutions.